Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress
Advanced Materials · 2024
DOI: 10.1002/adma.202310443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yang Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 3100…. Hauptthemen laut MEDLINE: Oxidative Stress, Liver Cirrhosis, Melatonin, Nanoparticles. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Central Guidance on Local Science and Technology Development Fund of Zhejiang Province, Key Project of Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province.
Abstract (Originalsprache)
Liver fibrosis represents a reversible stage of various chronic liver diseases that progresses to cirrhosis. This condition is characterized by an imbalance between tissue damage and repair, and the production of fibers in the liver exceeds their degradation. Oxidative stress (OS) resulting from tissue injury and endoplasmic reticulum stress (ERS) triggered by the overproduction of proteins are pivotal factors in liver fibrosis. Melatonin demonstrates the capability to neutralize free radicals, shielding cells from oxidative harm. It is also a specific inhibitor of the ERS receptor transcription activating factor 6 (ATF6), indicating its great potential in ameliorating liver fibrosis. However, its limited water solubility and oral bioavailability of under 15% present hurdles in achieving therapeutic blood concentrations for treating liver fibrosis. The PLGA@Melatonin is constructed by loading melatonin with poly (lactic‐co‐glycolic acid) (PLGA). Platelet membranes (PM) and activated hepatic stellate cell membranes (HSCM) with high expression of the platelet‐derived growth factor receptor (PDGFR) are extracted to successfully construct PM@PLGA@Melatonin and HSCM@PLGA@Melatonin, which are subsequently utilized to treat mice with liver fibrosis. The results illustrated the remarkable therapeutic effects of the two nanoparticles on liver fibrosis, along with their excellent targeting and biosafety properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- National Innovation Center for Fundamental Research on Cancer Medicine, Hangzhou, Zhejiang, 310009, China.
- Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- ZJU-Pujian Research & Development Center of Medical Artificial Intelligence for Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, 310058, China.
ORCID-Profile: Weilin Wang
Förderung
- National Natural Science Foundation of China
- Central Guidance on Local Science and Technology Development Fund of Zhejiang Province
- Key Project of Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
- Special Financial Support for Zhejiang Traditional Chinese Medicine Innovation Teams
- Basic Scientific Research Funds of Department of Education of Zhejiang Province
- Seed Fund of Zhejiang Provincial People's Hospital
Zitieren
APA
Bai, Y., Chen, J., Zhang, S., Xu, G., Mao, Z., Ding, Y., & Wang, W. (2024). Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress. Advanced Materials. https://doi.org/10.1002/adma.202310443
Vancouver
Bai Y, Chen J, Zhang S, Xu G, Mao Z, Ding Y, et al. Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress. Advanced Materials. 2024. doi:10.1002/adma.202310443
BibTeX
@article{Bai2024,
author = {Bai, Yang and Chen, Jiaqi and Zhang, Sitong and Xu, Guangyu and Mao, Zhengwei and Ding, Yuan and Wang, Weilin},
title = {Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202310443}
}
EUVIMED